Author

J.A. Soares

Observed name: J A Soares

Observed institution: Bristol-Myers Squibb (France)

OpenAlex ID: A5110051919

[Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes].

1994 · M Chazard, B Pellae-Cosset, et al. · PubMed · 13

Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study.

1996 · C Lhommé, P Kerbrat, et al. · PubMed · 9

378 Taxol® (paclitaxel) 225mg/m2 by 3-hour infusion without G-CSF as a second line therapy in patients (PTS) with metastatic breast cancer (MBC)

1995 · Ph. Bougnoux, R. Delva, et al. · European Journal of Cancer · 8

156 Phase II study of docetaxel (Taxotere®) in 1st and 2nd line NSCLC

1997 · G. Robinet, J.P. Kleisbauer, et al. · Lung Cancer · 6

PP-7-4 Phase study of taxol® (paclitaxel) in combination with epirubicin and cyclophosphamide without G-CSF as a first line treatment of metastatic breast carcinoma (MBC)

1996 · M.Tubiana Hulin, G. Catimel, et al. · European Journal of Cancer

Works count: 5

Citation count: 36

H-index: 4

I10-index: 1